Transparency Reporting for 2024
At Bayer, we believe in being open about how we work with healthcare professionals and organizations. Transparency helps build trust and strong relationships with the communities we serve.
Being transparent is part of our core value of Integrity. We aim to communicate clearly and honestly wherever we do business.
In Canada, we follow the voluntary disclosure guidelines created by Innovative Medicines Canada. As a member, Bayer supports high ethical standards and open communication in the pharmaceutical industry.
We regularly work with Canadian healthcare professionals and organizations. This includes consulting experts during product development, providing grants for scientific research, and sponsoring healthcare professionals to attend international conferences that benefit Canadian patients.
We’re proud to support medical education and other approved activities that help improve healthcare in Canada.
Data:
From January 1, 2024, to December 31, 2024, we are presenting the aggregate total of investment into the Canadian system in the following three categories:
Fee for HCP services: $4,101,382.37
Funding to HCOs: $8,415,762.67
Sponsorship of Scientific Exchange: $381,506.99
Explanatory Notes:
• Wherever our transparency systems capture this information, applicable taxes are included.
• Wherever our transparency systems capture this information, incidental expenses are included (for example parking and mileage).
• Funding for HCOs excludes Bayer’s R&D activities
• Transfers of value are captured according to the payment date, and not necessarily the date when the activity occurred.
Note: While Bayer makes every effort to present accurate and reliable information, Bayer makes no warranty and assumes no legal liability or responsibility for the accuracy or completeness of the information contained herein. Bayer shall not be liable for damages resulting from the use or misuse of the information contained on this website. Certain links may lead to resources located on servers that are not maintained by Bayer or under its control, and such hypertext links are provided as a convenience only. The inclusion of a link does not imply endorsement by or of the referenced site and Bayer is not responsible for the contents of or the availability of access to such websites.